153 related articles for article (PubMed ID: 25918138)
21. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
[TBL] [Abstract][Full Text] [Related]
22. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms.
Jefferson KK; Goldmann DA; Pier GB
Antimicrob Agents Chemother; 2005 Jun; 49(6):2467-73. PubMed ID: 15917548
[TBL] [Abstract][Full Text] [Related]
23. Study of the effect of antimicrobial peptide mimic, CSA-13, on an established biofilm formed by Pseudomonas aeruginosa.
Nagant C; Pitts B; Stewart PS; Feng Y; Savage PB; Dehaye JP
Microbiologyopen; 2013 Apr; 2(2):318-25. PubMed ID: 23436807
[TBL] [Abstract][Full Text] [Related]
24. The impact of a cation channel blocker (furosemide) on Pseudomonas aeruginosa PAO1 biofilm architecture.
Cross JL; Ramadan HH; Thomas JG
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):21-6. PubMed ID: 17599559
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model.
Cao B; Christophersen L; Thomsen K; Sønderholm M; Bjarnsholt T; Jensen PØ; Høiby N; Moser C
J Antimicrob Chemother; 2015 Jul; 70(7):2057-63. PubMed ID: 25786481
[TBL] [Abstract][Full Text] [Related]
26. Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
Ludwig E; Konkoly-Thege M; Kuti JL; Nicolau DP
Int J Antimicrob Agents; 2006 Nov; 28(5):433-8. PubMed ID: 17046212
[TBL] [Abstract][Full Text] [Related]
27. In vitro approach to study the synergistic effects of tobramycin and clarithromycin against Pseudomonas aeruginosa biofilms using prokaryotic or eukaryotic culture media.
Thellin O; Zorzi W; Jolois O; Elmoualij B; Duysens G; Cahay B; Streel B; Charif M; Bastin R; Heinen E; Quatresooz P
Int J Antimicrob Agents; 2015 Jul; 46(1):33-8. PubMed ID: 25963337
[TBL] [Abstract][Full Text] [Related]
28. Azithromycin retards Pseudomonas aeruginosa biofilm formation.
Gillis RJ; Iglewski BH
J Clin Microbiol; 2004 Dec; 42(12):5842-5. PubMed ID: 15583321
[TBL] [Abstract][Full Text] [Related]
29. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
Elkhatib W; Noreddin A
Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
[TBL] [Abstract][Full Text] [Related]
31. Mathematical modelling response of Pseudomonas aeruginosa to meropenem.
Tam VH; Schilling AN; Poole K; Nikolaou M
J Antimicrob Chemother; 2007 Dec; 60(6):1302-9. PubMed ID: 17913722
[TBL] [Abstract][Full Text] [Related]
32. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation.
Drenkard E; Ausubel FM
Nature; 2002 Apr; 416(6882):740-3. PubMed ID: 11961556
[TBL] [Abstract][Full Text] [Related]
33. Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms.
Du J; Bandara HM; Du P; Huang H; Hoang K; Nguyen D; Mogarala SV; Smyth HD
Mol Pharm; 2015 May; 12(5):1544-53. PubMed ID: 25793309
[TBL] [Abstract][Full Text] [Related]
34. The effects of D-Tyrosine combined with amikacin on the biofilms of Pseudomonas aeruginosa.
She P; Chen L; Liu H; Zou Y; Luo Z; Koronfel A; Wu Y
Microb Pathog; 2015 Sep; 86():38-44. PubMed ID: 26188263
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of colistin against biofilm by Pseudomonas aeruginosa is significantly improved under "cystic fibrosis-like" physicochemical conditions.
Pompilio A; Crocetta V; Pomponio S; Fiscarelli E; Di Bonaventura G
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):318-25. PubMed ID: 26004353
[TBL] [Abstract][Full Text] [Related]
36. Synthetic dendrimeric peptide active against biofilm and persister cells of Pseudomonas aeruginosa.
Bahar AA; Liu Z; Totsingan F; Buitrago C; Kallenbach N; Ren D
Appl Microbiol Biotechnol; 2015 Oct; 99(19):8125-35. PubMed ID: 26012420
[TBL] [Abstract][Full Text] [Related]
37. Nutrient dispersion enhances conventional antibiotic activity against Pseudomonas aeruginosa biofilms.
Sommerfeld Ross S; Fiegel J
Int J Antimicrob Agents; 2012 Aug; 40(2):177-81. PubMed ID: 22727773
[TBL] [Abstract][Full Text] [Related]
38. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa.
Delissalde F; Amábile-Cuevas CF
Int J Antimicrob Agents; 2004 Oct; 24(4):405-8. PubMed ID: 15380270
[TBL] [Abstract][Full Text] [Related]
39. Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.
Jakobsen TH; Bjarnsholt T; Jensen PØ; Givskov M; Høiby N
Future Microbiol; 2013 Jul; 8(7):901-21. PubMed ID: 23841636
[TBL] [Abstract][Full Text] [Related]
40. Effect of shear stress on growth, adhesion and biofilm formation of Pseudomonas aeruginosa with antibiotic-induced morphological changes.
Fonseca AP; Sousa JC
Int J Antimicrob Agents; 2007 Sep; 30(3):236-41. PubMed ID: 17574822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
